-
NewAmsterdam Pharma (NASDAQ:NAMS) Issues Earnings Results, Misses Estimates By $0.47 EPS
来源: Buzz FX / 27 2月 2025 14:56:19 America/New_York
NewAmsterdam Pharma (NASDAQ:NAMS) Issues Earnings Results, Misses Estimates By $0.47 EPS Written by MarketBeat February 27, 2025 Share Link copied to clipboard. NewAmsterdam Pharma ( NASDAQ:NAMS - Get Free Report ) announced its quarterly e
Read more...